1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Baseline characteristics of 202 randomized patients
PV Conservative Therapy P Value No. of patients 101 101 Age 75.2 ± 9.8 75.4 ± 8.4 .90 Female sex 70 (69%) 70 (69%) 1.0 Duration of back pain (days) 29.3 ± 17.1 26.8 ± 16.0 .46 Initial VAS 7.8 ± 1.5 7.5 ± 1.6 .12 Mean no. of VCFs at baseline (range) 2.4 ± 1.9 (1–5) 2.1 ± 1.5 (1–5) .24 No./grading of VCFs with bone edema 136 120 Mild 57 55 .59 Moderate 58 45 Severe 21 20 Wedge 90 97 .18 Biconcave 46 23 Crush 0 0 Vertebral level with bone edema T5-T10 19 32 .16 T11-L2 91 66 L3-L5 29 28 Bone density (t-score) −3.0 ± 1.17 −3.0 ± 1.05 .78